The German Primate Center

The German Primate Center (DPZ) in Göttingen, Germany, conducts basic research on and with primates in the areas of infectious diseases, neurosciences and organismic biology. In addition, it operates four field stations abroad and is a competence and reference center for primate research. The DPZ is one of the 88 research and infrastructure institutions of the Leibniz Association in Germany.

Address
Kellnerweg 4, 37077 Göttingen, Germany
Website
http://www.dpz.eu/

Subscribe to rss feed

Diseases, Conditions, Syndromes

Omicron variant largely resistant to current antibodies

The omicron variant of SARS-CoV-2 is spreading at an alarming rate. It could soon replace the delta variant, which at present dominates globally. However, little is known about whether currently available vaccines and drugs ...

Medications

Malaria drug chloroquine does not inhibit SARS-CoV-2

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2). In order to obtain an effective therapy for COVID-19 as quickly as possible, ...

Neuroscience

Why it doesn't get dark when you blink

People blink every five seconds. During this brief moment, no light falls on the retina, yet people continue to observe a stable picture of the environment with no intervals of darkness. Caspar Schwiedrzik and Sandrin Sudmann, ...

Neuroscience

Model describes complete grasping movement planning in the brain

Neuroscientists at the German Primate Center (DPZ)-Leibniz Institute for Primate Research in Göttingen have developed a model that can seamlessly represent the entire planning of movement from seeing an object to grasping ...

Diseases, Conditions, Syndromes

Delta and Delta Plus evade the antibody response

The emergence of new SARS-CoV-2 variants that can spread rapidly and undermine vaccine-induced immunity threatens the end of the COVID-19 pandemic. The delta variant (B.1.617.2) emerged in India and subsequently spread globally ...

HIV & AIDS

Developing a new vaccination strategy against AIDS

According to the WHO, there are currently more than 36 million people infected with the human immunodeficiency virus (HIV) and a further 2.4 million become infected every year. Despite treatment success against the virus, ...

Neuroscience

Better hearing with optical cochlear implants

Cochlear implants enable people with profound hearing impairment to gain a great deal in terms of quality of life, including understanding spoken words and developing normal speech. However, background noises are problematic; ...

Neuroscience

How we keep track of what matters

When watching basketball, we are easily able to keep track of the ball while also making frequent eye and head movements to look at the different players. Neuroscientists Tao Yao, Stefan Treue and B. Suresh Krishna from the ...

page 1 from 2